Free Trial

Clover Health Investments (CLOV) Short Interest Ratio & Short Volume

$0.99
-0.03 (-3.02%)
(As of 05:17 PM ET)

Clover Health Investments Short Interest Data

Current Short Interest
47,810,000 shares
Previous Short Interest
48,160,000 shares
Change Vs. Previous Month
-0.73%
Dollar Volume Sold Short
$30.12 million
Short Interest Ratio
5.1 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
496,440,000 shares
Percentage of Shares Shorted
9.63%
Today's Trading Volume
5,784,831 shares
Average Trading Volume
8,615,194 shares
Today's Volume Vs. Average
67%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Clover Health Investments ?

Sign up to receive the latest short interest report for Clover Health Investments and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CLOV Short Interest Over Time

CLOV Days to Cover Over Time

CLOV Percentage of Float Shorted Over Time

Clover Health Investments Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202447,810,000 shares $30.12 million -0.7%N/A5.1 $0.63
4/15/202448,160,000 shares $30.64 million +9.5%N/A5.2 $0.64
3/31/202443,980,000 shares $34.92 million -7.5%N/A4.7 $0.79
3/15/202447,540,000 shares $37.91 million +30.1%N/A4.9 $0.80
2/29/202436,540,000 shares $31.57 million +23.8%N/A4.3 $0.86
2/15/202429,520,000 shares $29.82 million +6.7%N/A3.9 $1.01
1/31/202427,680,000 shares $26.52 million -7.9%N/A3.7 $0.96
1/15/202430,040,000 shares $29.48 million +8.2%N/A4.2 $0.98
12/31/202327,760,000 shares $26.43 million +6.3%N/A4.1 $0.95
12/15/202326,110,000 shares $25.73 million +0.8%N/A4.4 $0.99
11/30/202325,900,000 shares $23.85 million +1.9%N/A5.4 $0.92
11/15/202325,430,000 shares $25.94 million +5.3%N/A6.2 $1.02
10/31/202324,150,000 shares $23.02 million -1.8%N/A5.7 $0.95
10/15/202324,600,000 shares $25.34 million -2.4%N/A6 $1.03
9/30/202325,200,000 shares $27.22 million +7.8%N/A5.1 $1.08
9/15/202323,370,000 shares $26.41 million +2.9%N/A3.8 $1.13
8/31/202322,720,000 shares $29.76 million +3.2%N/A2.7 $1.31
8/15/202322,020,000 shares $31.27 million +1.5%N/A2.4 $1.42
7/31/202321,700,000 shares $27.13 million -4.6%N/A2.2 $1.25
7/15/202322,740,000 shares $22.70 million -0.8%N/A2.4 $1.00
6/30/202322,930,000 shares $20.57 million -39.4%N/A2.5 $0.90
6/15/202337,830,000 shares $37.63 million +8.8%N/A4.6 $0.99
5/31/202334,780,000 shares $29.46 million -7.4%N/A5.5 $0.85
5/15/202337,550,000 shares $36.51 million -5.7%N/A5.6 $0.97
4/30/202339,820,000 shares $29.41 million +10.7%N/A6.3 $0.74
4/15/202335,960,000 shares $29.75 million +11.3%N/A5.7 $0.83
3/31/202332,320,000 shares $27.31 million +12.3%N/A5.1 $0.85
3/15/202328,780,000 shares $26.61 million -6.6%N/A4.1 $0.92
2/28/202330,800,000 shares $40.66 million +4.7%N/A4.5 $1.32
2/15/202329,420,000 shares $36.19 million +1.3%N/A4.9 $1.23
1/31/202329,030,000 shares $38.61 million -4.4%N/A4.3 $1.33
1/15/202330,380,000 shares $37.67 million -0.3%N/A4.4 $1.24
12/30/202230,480,000 shares $28.33 million +2.6%N/A4.2 $0.93
12/15/202229,710,000 shares $30.90 million No ChangeN/A4 $1.04
11/30/202229,710,000 shares $38.92 million -0.1%N/A4.1 $1.31
11/15/202229,740,000 shares $43.72 million -3.9%N/A4 $1.47
10/31/202230,950,000 shares $48.90 million -3.2%N/A4 $1.58
10/15/202231,960,000 shares $48.26 million -9.9%N/A4.2 $1.51
9/30/202235,480,000 shares $60.32 million +0.7%N/A5 $1.70
9/15/202235,240,000 shares $82.11 million -1.9%N/A4.6 $2.33
What is Nvidia’s New $1 Trillion Superproject? (Ad)

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.
8/31/202235,910,000 shares $93.73 million -0.2%N/A4.4 $2.61
8/15/202235,990,000 shares $116.97 million +0.3%N/A4.1 $3.25
7/31/202235,870,000 shares $100.44 million -1.1%N/A3.9 $2.80
7/15/202236,260,000 shares $90.29 million -6.4%N/A4 $2.49
6/30/202238,730,000 shares $82.88 million +27.8%N/A4.2 $2.14
6/15/202230,300,000 shares $67.57 million +3.8%N/A3.2 $2.23
5/31/202229,180,000 shares $77.91 million -5.1%N/A3.1 $2.67
5/15/202230,760,000 shares $80.28 million +4.6%N/A2.5 $2.61
4/30/202229,410,000 shares $79.11 million +0.9%N/A2.3 $2.69
4/15/202229,150,000 shares $90.66 million -3.2%N/A2.1 $3.11
3/31/202230,110,000 shares $106.89 million -8.3%N/A2 $3.55
3/15/202232,840,000 shares $94.58 million -9.6%N/A2.1 $2.88
2/28/202236,340,000 shares $98.84 million +7.0%N/A2.4 $2.72
2/15/202233,980,000 shares $86.99 million +21.6%N/A2.3 $2.56
1/31/202227,950,000 shares $72.11 million +6.5%N/A1.7 $2.58
1/15/202226,250,000 shares $81.64 million +6.3%N/A1.7 $3.11
12/31/202124,700,000 shares $91.88 million -4.8%N/A1.6 $3.72
12/15/202125,940,000 shares $107.13 million -1.3%N/A1.7 $4.13
11/30/202126,290,000 shares $130.40 million -17.7%N/A1.5 $4.96
11/15/202131,940,000 shares $241.47 million +9.5%N/A1.5 $7.56
10/29/202129,160,000 shares $218.70 million No ChangeN/A1.3 $7.50
10/15/202129,160,000 shares $230.66 million -8.4%N/A1.3 $7.91
9/30/202131,830,000 shares $235.22 million +2.6%N/A1.2 $7.39
9/15/202131,020,000 shares $253.43 million +1.3%N/A1 $8.17
8/31/202130,620,000 shares $262.72 million +1.2%N/A0.7 $8.58
8/13/202130,270,000 shares $248.82 million +19.8%N/A0.5 $8.22
7/30/202125,260,000 shares $203.85 million -11.7%18.9%0.5 $8.07
7/15/202128,610,000 shares $236.32 million -20.3%21.4%0.5 $8.26
6/30/202135,890,000 shares $478.05 million -13.3%27.8%0.6 $13.32
6/15/202141,400,000 shares $570.08 million +0.3%36.7%0.8 $13.77
5/28/202141,270,000 shares $315.30 million +2.0%36.6%1 $7.64
5/14/202140,460,000 shares $293.74 million +7.7%36.1%1.8 $7.26
4/30/202137,580,000 shares $382.19 million -2.9%34.2%1.6 $10.17
4/15/202138,700,000 shares $287.15 million +0.5%35.2%1.6 $7.42
3/31/202138,500,000 shares $276.82 million +30.0%12.6%2.3 $7.19
3/15/202129,620,000 shares $263.91 million +20.3%9.7%1.7 $8.91
2/26/202124,620,000 shares $239.06 million +24.0%8.0%1.4 $9.71
2/12/202119,850,000 shares $238.40 million +55.6%6.5%1.4 $12.01
1/29/202112,760,000 shares $179.53 million +40.1%N/A1 $14.07
1/15/20219,110,000 shares $127.63 million No Change12.6%1 $14.01

CLOV Short Interest - Frequently Asked Questions

What is Clover Health Investments' current short interest?

Short interest is the volume of Clover Health Investments shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 47,810,000 shares of CLOV short. Learn More on Clover Health Investments' current short interest.

What is a good short interest ratio for Clover Health Investments?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLOV shares currently have a short interest ratio of 5.0. Learn More on Clover Health Investments's short interest ratio.

Which institutional investors are shorting Clover Health Investments?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Clover Health Investments: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Clover Health Investments' short interest increasing or decreasing?

Clover Health Investments saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 47,810,000 shares, a decline of 0.7% from the previous total of 48,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Clover Health Investments' short interest compare to its competitors?

Here is how the short interest of companies compare to Clover Health Investments: Skillz Inc. (14.97%), Alignment Healthcare, Inc. (6.58%), Allogene Therapeutics, Inc. (32.03%), Voyager Therapeutics, Inc. (7.74%), Esperion Therapeutics, Inc. (11.79%), ZimVie Inc. (3.07%), Enhabit, Inc. (6.95%), Verve Therapeutics, Inc. (30.19%), Talkspace, Inc. (3.02%), Editas Medicine, Inc. (24.93%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Clover Health Investments stock?

Short selling CLOV is an investing strategy that aims to generate trading profit from Clover Health Investments as its price is falling. CLOV shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Clover Health Investments?

A short squeeze for Clover Health Investments occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLOV, which in turn drives the price of the stock up even further.

How often is Clover Health Investments' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLOV, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CLOV) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners